deltatrials
Completed PHASE1 NCT00004928

Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer

A Phase I Study of 1,25 Dihydroxy-Vitamin D3 (Calcitriol) in Patients With Prostate Cancer

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions Prostate Cancer
Interventions calcitriol zoledronic acid
Updated 5 times since 2017 Last updated: Jun 18, 2013 Started: Oct 31, 1999 Primary completion: Oct 31, 2004 Completion: Oct 31, 2004

Listed as NCT00004928, this PHASE1 trial focuses on Prostate Cancer and remains completed. Sponsored by Memorial Sloan Kettering Cancer Center, it has been updated 5 times since 1999, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Oct 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Memorial Sloan Kettering Cancer Center
  • National Cancer Institute (NCI)
Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • New York, United States